Skip to content
Trial Eligibility
Menu

Hypoparathyroidism Natural History Study

NCT05793853

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. The study objectives are to: Build a prospective cohort of patients to study HPT-associated end-organ damage. Determine end-organ physiologic consequences of HPT. Elucidate determinants of HPT-associated end-organ damage. Funding Source - FDA OOPD

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Hypoparathyroidism

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
December 16, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University Medical Center - Harkness Pavillion · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.